{ "cik": 1434868, "cik_padded": "0001434868", "entityName": "Esperion Therapeutics, Inc.", "fiscal_years": [ { "accn": "0001628280-26-016522", "filed": "2026-03-10", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 0.0, "cash": 167852000.0, "eps_diluted": -0.11, "free_cash_flow": -13093000.0, "net_income": -22682000.0, "operating_cash_flow": -13093000.0, "operating_income": 60273000.0, "revenue": 403135000.0, "stockholders_equity": -301965000.0, "total_assets": 465886000.0, "total_liabilities": 767851000.0 }, "period_end": "2025-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "net_margin": -0.05626403065970456, "operating_margin": 0.14951070981184963, "revenue_growth_yoy": 0.21311470476717803, "roa_avg2y": -0.05602520417879554, "roa_period_end": -0.04868572998544709, "roe_avg2y": 0.06567953356585544 } }, { "accn": "0001628280-26-016522", "filed": "2026-03-10", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 317000.0, "cash": 144761000.0, "eps_diluted": -0.28, "free_cash_flow": -23971000.0, "net_income": -51745000.0, "operating_cash_flow": -23654000.0, "operating_income": 54402000.0, "revenue": 332314000.0, "stockholders_equity": -388722000.0, "total_assets": 343821000.0, "total_liabilities": 732543000.0 }, "period_end": "2024-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "net_margin": -0.15571116474178037, "operating_margin": 0.16370661482814447, "revenue_growth_yoy": 1.856550965323981, "roa_avg2y": -0.18829475798601572, "roa_period_end": -0.1504998240363445, "roe_avg2y": 0.12265975754874862 } }, { "accn": "0001628280-26-016522", "filed": "2026-03-10", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 0.0, "cash": 82248000.0, "eps_diluted": -2.03, "free_cash_flow": -135487000.0, "net_income": -209248000.0, "operating_cash_flow": -135487000.0, "operating_income": -155563000.0, "revenue": 116334000.0, "stockholders_equity": -454994000.0, "total_assets": 205796000.0, "total_liabilities": 660790000.0 }, "period_end": "2023-12-31", "ratio_units": { "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "operating_margin": -1.33721010194784, "revenue_growth_yoy": 0.5413580655846306, "roa_avg2y": -0.9223357245969563, "roa_period_end": -1.0167738925926646, "roe_avg2y": 0.5373793613535155 } }, { "accn": "0001628280-26-016522", "filed": "2026-03-10", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 0.0, "cash": 124775000.0, "eps_diluted": -3.52, "free_cash_flow": -174827000.0, "net_income": -233659000.0, "operating_cash_flow": -174827000.0, "operating_income": -179501000.0, "revenue": 75475000.0, "stockholders_equity": -323778000.0, "total_assets": 247939000.0, "total_liabilities": 571717000.0 }, "period_end": "2022-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "revenue_growth_yoy": -0.037885451323823725, "roa_avg2y": -0.7423295829103981, "roa_period_end": -0.9424051883729466, "roe_avg2y": 0.897442397286844 } }, { "accn": "0001628280-25-011154", "filed": "2025-03-07", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 0.0, "cash": 208892000.0, "eps_diluted": -9.31, "free_cash_flow": -263809000.0, "net_income": -269108000.0, "operating_cash_flow": -263809000.0, "operating_income": -226730000.0, "revenue": 78447000.0, "stockholders_equity": -196944000.0, "total_assets": 381590000.0, "total_liabilities": 578534000.0 }, "period_end": "2021-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "revenue_growth_yoy": -0.6552492452108795, "roa_avg2y": -0.7324181327294896, "roa_period_end": -0.7052281244267408, "roe_avg2y": 1.836425797910454 } }, { "accn": "0001628280-23-004167", "filed": "2023-02-21", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 869000.0, "cash": 304962000.0, "eps_diluted": -5.23, "free_cash_flow": -86046000.0, "net_income": -143551000.0, "operating_cash_flow": -85177000.0, "operating_income": -121396000.0, "revenue": 227547000.0, "stockholders_equity": -96134000.0, "total_assets": 353258000.0, "total_liabilities": 449392000.0 }, "period_end": "2020-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "net_margin": -0.6308630744417637, "operating_margin": -0.5334985739209921, "revenue_growth_yoy": 0.5337076379714756, "roa_avg2y": -0.5057239235166151, "roa_period_end": -0.40636305476450635, "roe_avg2y": 3.7685340753964085 } }, { "accn": "0001628280-22-003263", "filed": "2022-02-22", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 953000.0, "cash": 166130000.0, "eps_diluted": -3.59, "free_cash_flow": -71294000.0, "net_income": -97165000.0, "operating_cash_flow": -70341000.0, "operating_income": -93101000.0, "revenue": 148364000.0, "stockholders_equity": 19950000.0, "total_assets": 214447000.0, "total_liabilities": 194497000.0 }, "period_end": "2019-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "net_margin": -0.6549095467903265, "operating_margin": -0.6275174570650562, "roa_avg2y": -0.5429759316900346, "roa_period_end": -0.4530956366841224, "roe_avg2y": -1.9615819437154278 } }, { "accn": "0001628280-22-003263", "filed": "2022-02-22", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 151000.0, "cash": 36973000.0, "free_cash_flow": -148789000.0, "net_income": -201810000.0, "operating_cash_flow": -148638000.0, "operating_income": -204585000.0, "stockholders_equity": 79118000.0, "total_assets": 143451000.0, "total_liabilities": 64333000.0 }, "period_end": "2018-12-31", "ratio_units": { "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "roa_avg2y": -0.9580664916470046, "roa_period_end": -1.4068218416044502, "roe_avg2y": -1.2464755457692651 } }, { "accn": "0001628280-21-002865", "filed": "2021-02-23", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 19000.0, "cash": 34468000.0, "free_cash_flow": -131321000.0, "net_income": -166988000.0, "operating_cash_flow": -131302000.0, "operating_income": -168982000.0, "stockholders_equity": 244691000.0, "total_assets": 277835000.0, "total_liabilities": 33144000.0 }, "period_end": "2017-12-31", "ratio_units": { "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "roa_avg2y": -0.6385188357473884, "roa_period_end": -0.6010329872046358, "roe_avg2y": -0.7056432273454287 } }, { "accn": "0001104659-20-026203", "filed": "2020-02-27", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 94000.0, "cash": 38165000.0, "free_cash_flow": -47824000.0, "net_income": -74978000.0, "operating_cash_flow": -47730000.0, "operating_income": -76150000.0, "stockholders_equity": 228602000.0, "total_assets": 245213000.0, "total_liabilities": 16611000.0 }, "period_end": "2016-12-31", "ratio_units": { "roa_period_end": "ratio" }, "ratios": { "roa_period_end": -0.30576682312927944 } } ], "latest_filing": { "accn": "0001628280-26-016522", "filed": "2026-03-10", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001434868.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001434868.json" }, "ticker": "ESPR" }